Artificial Intelligence
We apply a specialised, focused approach to the AI market.
Artificial Intelligence is rapidly catching up with the life sciences’ sector and big pharma. Growth within the market is shaped largely through biomedicine and healthcare. The outbreak of COVID-19 has made profound and enduring impacts on the health and life sciences industry. Consequently, the AI market in Life Sciences Market was valued at $1,255.3 million in 2020 and is estimated to be worth $5,402.1 million by 2026 presenting a compound annual growth rate of 29.13%.
Now more than ever, it is important for us to apply a specialised focused approach to help our clients maintain the rapid growth of this market.